Pulmonary Hypertension | Unmet Need | Pulmonary Arterial Hypertension | US/EU | 2016

launch Related Market Assessment Reports

• Retinal Vein Occlusion – Executive Insights – Executive Insights (US)

  September 2023

  Retinal vein occlusion (RVO) is a major cause of blindness in the major pharmaceutical markets. Patients are segmented by the anatomic location of the occlusion; thus, they are classified as having…

• Biomarkers In Oncology – Access & Reimbursement – Detailed, Expanded Analysis: Biomarkers In Oncology – Non-Small-Cell Lung Cancer, Breast Cancer, And Colorectal Cancer (US)

  September 2023

  Biomarker-driven prescribing is paramount in key oncology indications. The use of biomarkers is entrenched in non-small-cell lung cancer (NSCLC), breast cancer, and colorectal cancer. Biomarker-…

• Nonalcoholic Steatohepatitis – Current Treatment – Detailed, Expanded Analysis: Current Treatment: Physician Insights (US)

  September 2023

• Systemic Lupus Erythematosus – Landscape & Forecast – Disease Landscape & Forecast

  September 2023

  Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect nearly any organ or system in the body. As a result, its course, manifestations, and treatment approach can be…

• Glaucoma – Unmet Need – Detailed, Expanded Analysis (US/EU)

  September 2023

  Glaucoma is a progressive disease of the optic nerve caused by high intraocular pressure (IOP); it is one of the leading causes of vision loss in the United States and Europe. The majority of…